Stay updated on Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A new MARIPOSA publication citation (Lazertinib versus Osimertinib in EGFR-mutant NSCLC; J Thorac Oncol 2025) was added on 2026-05-08. Additionally, May 2026 date entries were added (2026-05-07 and 2026-05), and April 2026 entries (2026-04-22, 2026-04-09, 2026-04) were removed.
    Difference
    0.1%
    Check dated 2026-05-14T01:46:42.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The study locations section was updated to add new sites in China and Turkey and to increase the total number of locations to 269; several previously listed sites were removed (Beijing Cancer Hospital, Hunan Cancer Hospital, Ankara 6560, Gazi University Hospital, National Cancer Institute, The Royal Marsden NHS Trust), reflecting a revision to the study's site roster.
    Difference
    0.3%
    Check dated 2026-04-28T14:37:54.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page revision/version indicator was updated from v3.5.0 to v3.5.2. No study content or key details were changed.
    Difference
    0.0%
    Check dated 2026-04-21T09:28:51.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Napoli, Italy 80100 was replaced with Naples, Italy 80100. The Naples location was added and Napoli removed; page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-23T13:54:53.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-09T01:58:32.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Revision: v3.4.2 replaces v3.4.1 as a minor internal update with no user-facing content or functionality changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-15T15:16:29.000Z thumbnail image

Stay in the know with updates to Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab Combo vs. Osimertinib in NSCLC Clinical Trial page.